Screener
Lantheus Holdings LNTH CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Lantheus Holdings in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForCapitalImprovements.
The source filing: Lantheus Holdings’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336795
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued expenses and other current and noncurrent liabilities | 21,015 | (2,619) |
| Net cash provided by operating activities | 217,330 | 194,669 |
| Cash flows from investing activities: | ||
| Capital expenditures | (5,561) | (16,679) |
| Acquisition of in-process research and development | — | (5,413) |
| Proceeds from sale of business, net of transaction costs | 24,212 | — |
| Proceeds from sale of assets | 5,000 | — |
| Acquisition of Lantheus Biosciences, net of cash acquired | 312 | — |
Item 1. Financial Statements
FAQ
- What is Lantheus Holdings's capex?
- Lantheus Holdings (LNTH) reported capex of $2.34M in Q2 2026.
- How has Lantheus Holdings's capex changed year-over-year?
- Lantheus Holdings's capex decreased by 70.7% year-over-year, from $7.96M to $2.34M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Lantheus Holdings's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude